13th week of 2019 patent applcation highlights part 8 |
Patent application number | Title | Published |
20190091109 | PROCESS FOR THE PRODUCTION OF ANTIMICROBIAL DENTAL ADHESIVES INCLUDING GRAPHENE AND RELATIVE PRODUCT THEREOF | 2019-03-28 |
20190091111 | THERMOPLASTIC DENTURE FRAMES, METHODS FOR MAKING THERMOPLASTIC DENTURE FRAMES AND DENTURES CONTAINING THERMOPLASTIC DENTURE FRAMES | 2019-03-28 |
20190091112 | REMOVER SET | 2019-03-28 |
20190091113 | POSITIVE PRESSURE FLOW SKIN ABRASION SYSTEM AND METHOD FOR DERMAL REJUVENATION | 2019-03-28 |
20190091114 | FACIAL MASK SET | 2019-03-28 |
20190091115 | CONDITIONER COMPOSITIONS WITH POLYACRYLATE MICROCAPSULES HAVING IMPROVED LONG-LASTING ODOR BENEFIT | 2019-03-28 |
20190091116 | COMPOSITION COMPRISING STABILIZED POLYMER PARTICLES AND A HYDROPHOBIC FILM-FORMING POLYMER | 2019-03-28 |
20190091117 | Dentifrice Comprising Zinc-Amino Acid Complex and Phosphates | 2019-03-28 |
20190091118 | AGENT FOR TREATING DYED HAIR | 2019-03-28 |
20190091119 | METHODS, COMPOSITIONS AND USES RELATING THERETO | 2019-03-28 |
20190091120 | METHODS, COMPOSITIONS AND USES RELATING THERETO | 2019-03-28 |
20190091121 | METHODS, COMPOSITIONS AND USES RELATING THERETO | 2019-03-28 |
20190091122 | COSMETIC COMPOSITIONS AND METHOD OF TREATING THE SKIN | 2019-03-28 |
20190091123 | DYE COMPOSITION COMPRISING A PARA-PHENYLENEDIAMINE OXIDATION BASE AND AN ADDITIONAL BASE | 2019-03-28 |
20190091124 | AQUEOUS N-ACYL AMINO ACID SOLUTIONS | 2019-03-28 |
20190091125 | Methods of Improving the Activity of Retinoids | 2019-03-28 |
20190091126 | LATE STAGE ADDITION OF RHEOLOGY MODIFIER | 2019-03-28 |
20190091127 | AGENTS AND METHODS FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS | 2019-03-28 |
20190091128 | COMPOSITION OF GEL-GEL TYPE COMPRISING STABILIZED POLYMER PARTICLES | 2019-03-28 |
20190091129 | PERSONAL CARE COMPOSITIONS CONTAINING COMPLEXING POLYELECTROLYTES | 2019-03-28 |
20190091130 | METHODS FOR IMPROVING THE APPEARANCE OF SKIN IMPERFECTIONS | 2019-03-28 |
20190091131 | STRIPPABLE AQUEOUS COSMETIC NAIL VARNISH COMPOSITION CONTAINING STABILISED POLYURETHANE | 2019-03-28 |
20190091132 | COSMETIC COMPOSITIONS CAPABLE OF FORMING A MULTILAYER STRUCTURE AFTER APPLICATION TO A KERATINOUS MATERIAL | 2019-03-28 |
20190091133 | PET CARE CLEANSING COMPOSITION | 2019-03-28 |
20190091134 | COMPOSITIONS AND METHODS FOR IMPROVING THE APPEARANCE OF THE SKIN | 2019-03-28 |
20190091135 | NICOTINE FORMULATION | 2019-03-28 |
20190091136 | THERMALLY NEUTRAL INHALATION GAS COMPOSITION | 2019-03-28 |
20190091137 | Topical treatment for warts using film forming polymers | 2019-03-28 |
20190091138 | FORMULATIONS OF PTHRP ANALOGUES, TRANSDERMAL PATCHES THEREOF, AND USES THEREOF | 2019-03-28 |
20190091139 | MULTI-LAYER HYDROGEL CAPSULES FOR ENCAPSULATION OF CELLS AND CELL AGGREGATES | 2019-03-28 |
20190091140 | DRUG DELIVERY DEVICE | 2019-03-28 |
20190091141 | GEOMETRICALLY COMPLEX INTRAVAGINAL RINGS, SYSTEMS AND METHODS OF MAKING THE SAME | 2019-03-28 |
20190091142 | METHOD OF TREATING AN EYE DISORDER BY INHIBITING OR DISRUPTING BACTERIAL BIOFILM FORMATION | 2019-03-28 |
20190091143 | NERIDRONIC ACID FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2019-03-28 |
20190091144 | PET FOOD INCLUDING CANNABIDIOLIC ACID | 2019-03-28 |
20190091145 | Probiotic Tablet Formulations | 2019-03-28 |
20190091146 | Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate | 2019-03-28 |
20190091147 | Preparation Method for Charge Reversaland Reversibly Crosslinked Redox-Sensitive Nanomicelles | 2019-03-28 |
20190091148 | TOPICAL COMPOSITION AND METHOD FOR TREATING AND PREVENTING ATOPIC DERMATITIS AND INFECTIONS RELATED TO BACTERIA BIOFILM | 2019-03-28 |
20190091149 | Oil foamable carriers and formulations | 2019-03-28 |
20190091150 | POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY AND METHODS OF USING SAME | 2019-03-28 |
20190091151 | FRANCISELLA LIPIDS AS BROAD ANTI-INFLAMMATORY THERAPEUTICS AND ASSOCIATED METHODS OF USE | 2019-03-28 |
20190091152 | USE OF UMIROLIMUS AND ITS DERIVATIVES FOR TREATING CANCER | 2019-03-28 |
20190091153 | PREPARING METHOD FOR POSITIVELY-ELECTRIFIED CHARGED NIOSOME, AND CHARGED NIOSOME | 2019-03-28 |
20190091154 | HIGH DENSITY LIPOPROTEIN FUNCTIONALIZED MAGNETIC NANOSTRUCTURES | 2019-03-28 |
20190091155 | COMBINATION TABLET WITH CHEWABLE OUTER LAYER | 2019-03-28 |
20190091156 | MILRINONE CONTROLLED-RELEASE FORMULATION | 2019-03-28 |
20190091157 | Method of Making a Soft Gel Capsule Comprising COQ-10 Solubilized in a Monoterpene | 2019-03-28 |
20190091158 | COMPOSITIONS COMPRISING AT LEAST ONE DISPERSED ACTIVE PRINCIPLE AND LIPID MICROCAPSULES | 2019-03-28 |
20190091159 | ORALLY AVAILABLE ARTICLES CONTAINING AT LEAST ONE STABILIZED SUPPLEMENT THEREIN | 2019-03-28 |
20190091160 | BACTERIALLY-DERIVED, INTACT MINICELLS THAT ENCOMPASS PLASMID-FREE FUNCTIONAL NUCLEIC ACID FOR IN VIVO DELIVERY TO MAMMALIAN CELLS | 2019-03-28 |
20190091161 | Nanogel-Mediated Drug Delivery | 2019-03-28 |
20190091162 | POLYMER-LIPID HYBRID NANOPARTICLES OF CAPECITABINE UTILIZING MICROMIXING AND CAPECITABINE AMPHIPHILIC PROPERTIES | 2019-03-28 |
20190091163 | NANO-SIZED DRUG DELIVERY STRUCTURE | 2019-03-28 |
20190091164 | Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making And Using Same | 2019-03-28 |
20190091165 | METHOD FOR PREPARING NANOPARTICLE OF ACTIVE INGREDIENT USING LIPID AS LUBRICANT IN MILLING PROCESS | 2019-03-28 |
20190091166 | BIOABSORBABLE SHEET OR FILM | 2019-03-28 |
20190091167 | ANTIBACTERIAL NANOFIBER | 2019-03-28 |
20190091168 | FORMULATION FOR ENHANCED TRANSDERMAL ABSORPTION OF DRUG | 2019-03-28 |
20190091169 | METHOD OF MAKING CASEIN PARTICLES ENCAPSULATING THERAPEUTICALLY ACTIVE AGENTS AND USES THEREOF | 2019-03-28 |
20190091170 | COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY AND OTHER DISORDERS | 2019-03-28 |
20190091171 | Use of Cannabinoids in the Treatment of Epilepsy | 2019-03-28 |
20190091172 | Carotenoids as anti-hypertension agents | 2019-03-28 |
20190091173 | METHOD OF INCREASING TIME BETWEEN CONVULSIVE SEIZURES | 2019-03-28 |
20190091174 | METHOD OF REDUCING SEIZURE TYPE EXPERIENCED BY A DRAVET PATIENT | 2019-03-28 |
20190091175 | METHOD OF REDUCTION MEDICATION IN TREATING DRAVET SYNDROME | 2019-03-28 |
20190091176 | METHOD OF TREATING SELECTED PATIENT POPULATION EXPERIENCING DRAVET SYNDROME | 2019-03-28 |
20190091177 | METHOD OF TREATING SELECTED PATIENT POPULATION EXPERIENCING DRAVET SYNDROME | 2019-03-28 |
20190091178 | KETOGENIC DIET COMPATIBLE FENFLURAMINE FORMULATION | 2019-03-28 |
20190091179 | CONGNITIVE FUNCTION WITH FENFLURAMINE | 2019-03-28 |
20190091180 | DOSAGE REGIMEN FOR A S1P RECEPTOR AGONIST | 2019-03-28 |
20190091181 | MITORIBOSCINS: MITOCHONDRIAL-BASED THERAPEUTICS TARGETING CANCER CELLS, BACTERIA, AND PATHOGENIC YEAST | 2019-03-28 |
20190091182 | AQUAPORIN 4 FUNCTION PROMOTOR AND PHARMACEUTICAL COMPOSITION FOR NEUROLOGICAL DISORDERS | 2019-03-28 |
20190091183 | REDOX-ACTIVATED PRO-CHELATORS | 2019-03-28 |
20190091184 | ROLES OF MODULATORS OF INTERSECTIN-CDC42 SIGNALING IN ALZHEIMER'S DISEASE | 2019-03-28 |
20190091185 | Solid Solution Compositions and Use in Chronic Inflammation | 2019-03-28 |
20190091186 | PREVENTION, TREATMENT AND REVERSAL OF DISEASE USING THERAPEUTICALLY EFFECTIVE AMOUNTS OF DICARBOXYLIC ACID COMPOUNDS | 2019-03-28 |
20190091187 | COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS INCLUDING GLIOMAS | 2019-03-28 |
20190091188 | Therapy for Transthyretin-Associated Amyloidosis | 2019-03-28 |
20190091189 | ADMINISTRATION OF EXOGENOUS KETONE TO LOWER BLOOD GLUCOSE | 2019-03-28 |
20190091190 | COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS | 2019-03-28 |
20190091191 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | 2019-03-28 |
20190091192 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | 2019-03-28 |
20190091193 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER | 2019-03-28 |
20190091194 | METHODS OF TREATING AND PREVENTING ENDOTHELIAL DYSFUNCTION USING BARDOXOLONE METHYL OR ANALOGS THEREOF | 2019-03-28 |
20190091195 | USE OF DIANHYDROGALACTITOL AND DERIVATIVES THEREOF IN THE TREATMENT OF GLIOBLASTOMA, LUNG CANCER, AND OVARIAN CANCER | 2019-03-28 |
20190091196 | Pharmaceutical Compositions of Dimethyl Fumarate | 2019-03-28 |
20190091197 | POTENTIATED TULATHROMYCIN | 2019-03-28 |
20190091198 | CANNABIONID AND CANNABIS-BASED COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS OF THE GASTROINTESTINAL TRACT | 2019-03-28 |
20190091199 | THE USE OF HOMOERIODICTYOL (HED) FOR REDUCING THE GASTRIC ACID SECRETION-STIMULATING EFFECT OF N-ACETYL-4-AMINOPHENOL (PARACETAMOL) | 2019-03-28 |
20190091200 | ULTRAPURE TETRAHYDROCANNABINOL-11-OIC ACIDS | 2019-03-28 |
20190091201 | PKC-DELTA-I INHIBITOR FORMULATIONS AND USES THEREOF | 2019-03-28 |
20190091202 | PHARMACEUTICAL AGENTS TARGETING CANCER STEM CELLS | 2019-03-28 |
20190091203 | DOSAGE REGIMEN FOR THE TREATMENT OF ACUTE EXACERBATIONS OF INFLAMMATORY CONDITIONS | 2019-03-28 |
20190091204 | COMPOSITIONS OF DEFERASIROX | 2019-03-28 |
20190091205 | Methods and compositions for inhibiting mutant EGFR signaling | 2019-03-28 |
20190091206 | SMALL MOLECULE DUAL-INHIBITORS OF TRPV4 AND TRPA1 FOR SANITIZING AND ANESTHETIZING | 2019-03-28 |
20190091207 | Treatment Of CDKL5 Disorders With GSK3B Inhibitor Tideglusib | 2019-03-28 |
20190091208 | USE OF FK506 FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION | 2019-03-28 |
20190091209 | METHODS AND COMPOSITIONS FOR TREATMENT OF EPILEPTIC DISORDERS | 2019-03-28 |